Tue, Nov 10, 2026
A A A
Welcome Guest
Free Trial RSS pod
Get FREE trial access to our award winning publications
Alternative Market Briefing

Performance: 788 China Fund Ltd. down YTD -57% after +114% in 2007, Healthcare hedge fund Accipiter Life Sciences II loses 40% in March, Platinum Grove suffers worst performance since inception in March

Friday, April 11, 2008

Opalesque Exclusive: 788 China Fund Ltd. down YTD -57% after +114% in 2007 The 788 China Fund Ltd., which had past annual gains of +33.28% (2006) and +114.82% (2007), began 2008 with a January loss of -39.55% and after a brief February bounce back of +7.63% estimates March returns to be -33.91%. According to corporate documents the fund, managed by Jacques Mechelany, aims to achieve medium to long term growth by investing in Chinese and Chinese related financial markets.

According to these documents, "the Fund is designed to provide global investors with a unique vehicle through which to invest in China, with a favorably biased risk/reward ratio. Up to 80 % of the Fund will be invested through highly liquid indices, with constant stop losses and the ability to remain in cash during negative market trends.

Meanwhile, the Eurekahedge Greater China Hedge Fund Index is -4.65% for March as of today. Corporate website: Source

Healthcare hedge fund Accipiter Life Sciences II loses 40% in March From WSJ's MarketBeat: It has been one of the worst quarters for hedge funds in years. Just ask Gabe Hoffman. Mr. Hoffman, who focuses on healthcare stocks, saw a loss of 40.7% in March alone in his biggest fund, Accipiter Life Sciences II.

The Accipiter Life Sciences II is down 29% year to date, through April 4th, after last year’s 20.4% rise. His other fund, called Accipi......................

To view our full article Click here

Previous Opalesque Exclusives                                  
Previous Other Voices                                               
Access Alternative Market Briefing

 



  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Opalesque Exclusive: DACH institutions push alternatives to 32.3% of portfolios as hedge funds make a comeback[more]

    Matthias Knab, Opalesque for New Managers: Institutional investors in Germany, Austria and Switzerland now hold almost a third of their portfolios in alternative investments, and they are more confident than ever in

  2. KRX chief courts CalPERS for bigger bet on Korea[more]

    Korea Exchange Chairman and CEO Jeong Eun-bo held talks with California Public Employees' Retirement System, or CalPERS, to promote greater investment in South Korea's capital markets, the bourse operator announced Wednesday. Jeong met with CalPERS Chief Investment Officer Stephen Gilmore.

  3. 755 Unicorns, $8 Trillion: Fifth Era maps the autonomous digital economy[more]

    Matthias Knab, Opalesque for New Managers: Fifth Era Partners, a specialized asset manager focused on the convergence of Internet, AI/Agentic and Blockchain technologies, has released the findings of its 13th Bia

  4. Opalesque Exclusive: "Enough beta plays" - how Fasanara builds an alpha-only multi-strategy platform[more]

    Matthias Knab, Opalesque for New Managers: Most multi-strategy funds promise diversification. Fewer can explain why their return streams should stay independent when markets turn. In an Opalesque SkillsLab investor

  5. Opalesque Exclusive: Governance, Scale, and Boutique Resilience in a Consolidating Hedge Fund Industry[more]

    Matthias Knab, Opalesque for New Managers: The hedge fund industry has undergone significant consolidation in recent years, with capital increasingly concentrated among large multi-strategy platforms. Yet boutique m